Penumbra Q2 revenue $339.5M (+13.4% YoY); net income $45.3M vs prior-year loss

Penumbra Inc

2025-Q2 EPS reported $2.15 revenue$663,595,000

Revenue $339.5M, +13.4% YoY; U.S. Thrombectomy $188.5M (+22.6%); U.S. VTE +42%.
Net income $45.3M vs loss from operations of $81.0M in Q2 2024; operating margin 12.0%.
Adjusted EBITDA $61.4M (18.1% margin); gross margin improved to 66.0% from 54.4% (ex $33.4M one-time charge).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.